The company has entered into an 'in-licencing agreement' with Gilead Sciences Inc to produce and sell, under licence, three new HIV/AIDS drugs which are currently in late stages of clinical development, Ranbaxy Laboratories said.
A total 87,374 people have recuperated in a span of 24 hours in the country, while the number of new confirmed cases reported is 86,508, according to the data updated at 8 am.
The chronic dry eye is a common disease in which natural tears fail to adequately lubricate the eyes, thus drastically affecting its functioning.
Five COVID-19 patients have suffered cytomegalovirus-related rectal bleeding at a leading private facility in New Delhi during the second wave of the pandemic, hospital authorities said on Tuesday and claimed it was being reported for the 'first time' in immunocompetent persons.
After discussion with the Food and Drug Administration (FDA), the companies recently elected to drop the 32-case interim analysis and conduct the first interim analysis at a minimum of 62 cases, the statement said.
One Chinese source informed ANI that 10 million new infections are probably occurring daily in China.
As many as 29,557 COVID-19 patients have recuperated in the past 24 hours.
The device is powered by AI engine that conducts risk analysis on an individual's health data to note the slightest of deviations from their healthy baselines and detect any early signs of health deterioration.
Scientists around the world, including in India, suggest it hasn't been tested properly given the time constraint and there may not be enough evidence to prove its efficacy.
PLSL's lead molecule under development for cancer treatment has completed two Phase-I studies.
Named after 'Feluda', the detective character in legendary filmmaker Satyajit Ray's stories, the test has been developed by Debojyoti Chakraborty and Souvik Maiti as a simpler way of detecting SARS-coV2 presence in clinical samples, IGIB Director Anurag Agarwal said.
The Omicron variant carries 'concerning' mutations that may make it more transmissible and allow it to evade immunity, scientists said on Monday, stressing that the one certainty in the uncertainty of the many things unknown is this -- COVID is not a short-term crisis and vaccines are still a critical tool.
"The spike in the daily recovered COVID-19 patients continues in the country. For the second successive day, India has clocked a record recovery of more than 70,000 patients in a single day," the government said.
Women are great team players and collaborators, 'but they don't put themselves forward,' Dr Gagandeep Kang, the first Indian woman scientist to be elected as a Fellow of the Royal Society, tells Veenu Sandhu.
Professor Shankar Balasubramanian has been awarded the prize, worth 10,000 pounds, for his work on Solexa sequencing, the high speed genome sequencing technology that means it is now possible to sequence a human genome for less than $10,000.
Without naming the entity, he said some players are at a pre-clinical stage and may reach the clinical stage by October. Responding to a question on absence of a vaccine currently and the prospects in the next few months as the lockdown eases, VijayRaghvan emphasised on aggressive rapid testing and tracking.
A whitepaper released by the Chinese government gave a lengthy explanation to refute the allegations of cover up and delay by Beijing on reporting the COVID-19 outbreak last year in Wuhan. United States President Donald Trump and leaders of several countries have accused China of not being transparent in reporting the deadly disease, leading to huge human casualties and economic crisis across the world.
This doctor couple put their faith in India. And in return India has put faith in them.
'Nobody is attacking the company or the vaccine.' 'The concerns are about the process and the lack of transparency.'
Chinese officials hope the cases will come down in the coming days with more specialised hospitals being set up in Wuhan. China's ministry of science and technology said that a batch of Remdesivir, an antiviral drug, which will be put into clinical trials to test its efficiency on the novel coronavirus (2019-nCoV), is expected to arrive in China soon.
'We can't rule out the fact that the virus might have changed in such a way that it's actually causing more harm to young people.'
The EUA allows for Remdesivir to be distributed in the US and administered intravenously by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe condition.
To address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously developed Covaxin outside India, sources said.
'There is no data to show this virus is more deadlier.'
The first COVID-19 vaccine shots in India were given on Saturday to nearly two lakh frontline healthcare and sanitary workers as Prime Minister Narendra Modi rolled out the world's largest inoculation drive against the pandemic that has caused 1,52,093 deaths and upended millions of lives in the country.
Addressing a press briefing, health ministry Joint Secretary Lav Agarwal said currently there are no approved therapies for COVID-19 and there is not enough evidence to claim that plasma therapy can be used for treatment of the disease.
'On January 17, we had our first meeting with the Cabinet secretary.' 'Different secretaries belonging to different departments attended it.' 'It was only two weeks when China had said there is a new disease.' 'So, we gave the quickest response.'
Vice President Mike Pence said Trump had authorised a ban on entry of foreign nationals who travelled to Iran in the last 14 days. The United States also advised its citizens not to travel to parts of South Korea and Italy, from where reports of coronavirus have appeared.
While Covishield supplies would meet the target of 500 mn doses between August and December, it looks like Covaxin would miss the target of 400 mn unless the partner sites of Bharat Biotech ramp up very rapidly, reports Sohini Das.
With these states imposing lockdowns anew, the health ministry emphasised that the restrictions should be utilised to focus on containment, surveillance and testing in the containment and buffer zones as the key strategy for early detection of cases and fatality management.
A group of public health experts, including doctors from All India Institute of Medical Sciences and members from the national taskforce on COVID-19, have said that mass, indiscriminate and incomplete vaccination can trigger emergence of mutant strains and recommended that there is no need to inoculate those who had documented coronavirus infection.
GlaxoSmithKline Pharmaceuticals Limited is expanding its clinical trial data management, analyses and reporting activities in India where it plans to double the headcount depending on business needs.
Researchers at Northwell Health in New York are testing the effects on Famotidine (used in high intravenous doses) on Covid-19 patients as a potential treatment. After the hospital announced its clinical trials, it led to a drug shortage in the US. Back home, however, there has not been any surge in the demand for Famotidine yet.
'The group having rice flour and wheat flour showed an increase in glycosylated haemoglobin (HbA1c), and the group that took the jackfruit flour had a significant decrease in HbA1c.' 'Our results showed a decrease in fasting blood glucose (FBG) and postprandial glucose (PPG) after the green jackfruit flour meal.'
"Pregnancy doesn't increase the risk of acquiring SARS-COV-2 infection but appears to worsen the clinical course as compared to non-pregnant women'
Tata Memorial Hospital, Mumbai, invites applications for its Master's Course in Epidemiology and Clinical Research in Oncology.
Initial data has shown immunity triggered by the two mRNA vaccines -- Pfizer-BioNTech and Moderna -- lasts for at least six months
The company claimed that the AYUSH ministry has "categorically agreed" that Patanjali had "appropriately worked on COVID-19 management".
Poonawalla, during an interaction with Odisha Chief Minister Naveen Patnaik through a video conference, expressed optimism that the COVID-19 vaccine could be ready by October-November this year and the next phase of the trial can start in mid-August in India. According to a press note released by the CMO, Poonawalla has informed that the Oxford University vaccine has shown promising results in the first phase trial.
Following a six-day schedule, reducing class size, setting up isolation facilities on campus, and COVID-19 screening of students, faculty and staff are among the guidelines announced by the University Grants Commission (UGC) for reopening of universities and colleges closed since March in view of the pandemic.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances